ClinicalTrials.gg

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Suzhou Zelgen Biopharmaceuticals Co.,Ltd clinical trials

Its pipeline, or its studies — you choose. Free with an account during the beta.

The registry lists 83 studies whose lead sponsor is Suzhou Zelgen Biopharmaceuticals Co.,Ltd. 29 are recruiting or about to start. Per ClinicalTrials.gov, last updated Nov 16, 2026.

Our grouping of 1 registry name, not the registry’s. See them and correct one ↓

Compare Suzhou Zelgen Biopharmaceuticals with Innovent Biologics and Jiangsu HengRui Medicine →

Pipeline: 5 programs

Each counted once: 5 with a study Suzhou Zelgen Biopharmaceuticals Co.,Ltd leads registered in the last two years.

  • Phase 2
  • Phase 3

The 3 phase-3 programs — sign in to see them, free: with every program, filter by condition or phase and sort by first study or primary completion.

“Registry” is the highest phase of Suzhou Zelgen Biopharmaceuticals Co.,Ltd’s own registered studies; Suzhou Zelgen Biopharmaceuticals Co.,Ltd’s own pipeline document is not read yet. “Primary completion” is the earliest date still ahead among its live studies when the main measure’s data collection ends, as the registry states it (most are estimates); results come later, if they are announced. Programs are read from ClinicalTrials.gov, joined across names by rules and decisions each recorded with its evidence.

What it is testing

The drugs Suzhou Zelgen Biopharmaceuticals Co.,Ltd’s studies test, most open studies first — 12 drugs with a page of their own. Each count opens the studies in search.

Open now Not open: under way, finished or stopped

Show 2 more

Coming up

10 of Suzhou Zelgen Biopharmaceuticals Co.,Ltd’s studies under way reach primary completion within a year. The dates are the sponsor’s own estimates, which often move.

Phase 3 Other phases

  1. N’26
  2. 1D
  3. J’27
  4. 1F
  5. M
  6. 3A
  7. 2M
  8. J
  9. J
  10. 1A
  11. 1S
  12. 1O
  13. N

Add all 10 to your calendar (.ics) → With an account.

What changed recently

From the registry's own updates since Oct 20, 2026.

All 83 at a glance

Where each study is in its life, its phase and its countries. Each count opens them in search.

  • Open now2935%Recruiting 22 · Not yet recruiting 7
  • Under way, not recruiting45%
  • Completed3846%
  • Stopped early911%Terminated 8 · Withdrawn 1
  • Status unknown or other34%

Phase

Where

  • China80
  • United States2

Over the years

  1. 14
  2. 15
  3. 16
  4. 17
  5. 18
  6. 19
  7. 20
  8. 21
  9. 22
  10. 23
  11. 24
  12. 1225
  13. 526

By the year each study started. 2026 so far in the lighter column.

Registry sponsor names on this page

Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.

Tell us about a missing company
No account needed. Please leave out personal details.

Each name exactly as ClinicalTrials.gov lists it, and how it relates to Suzhou Zelgen Biopharmaceuticals Co.,Ltd.

  • Suzhou Zelgen Biopharmaceuticals Co.,Ltd
    Same company
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    83 studies

Studies

Recruiting first, then most recently updated. Showing 50 of 83. Browse all 83 →